Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Eli Lilly and Company and Sitryx, an Oxford, UK-based biopharmaceutical company focused on developing therapeutics in immuno-oncology and immuno-inflammation, have entered a licensing pact in a deal worth up to $880 million ($50 million...

Takeda has formed a licensing pact with Evox Therapeutics, an Oxford, UK-headquartered biopharmaceutical company, in a deal worth up to $882 million ($44 million upfront) for the development of protein-replacement and mRNA therapies. The...

A roundup of developments from India (Bayer, GSK), the US (Boehringer Ingelheim, Lilly, Tetraphase, Amicus), and Japan (Amgen). India Bayer, Curadev Sign Agreement To Develop STING Antagonists Program Bayer and Curadev, a small-molecule...